Epinephrine infusion increases adipose interleukin-6 gene expression and systemic levels in humans

被引:17
作者
Keller, P
Keller, C
Robinson, LE
Pedersen, BK
机构
[1] Copenhagen Univ Hosp, Dept Infect Dis, DK-2200 Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Copenhagen Muscle Res Ctr, DK-2200 Copenhagen, Denmark
关键词
interleukin-6; receptor; tumor necrosis factor; adipose tissue;
D O I
10.1152/japplphysiol.00284.2004
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Exercise increases IL-6 mRNA in subcutaneous adipose tissue; however, the immediate signal for the IL-6 induction is unknown. We, therefore, explored the possible role of epinephrine in the induction of IL-6 in adipose tissue. Subcutaneous adipose tissue biopsies and blood samples were obtained from eight healthy men (mean age 27 yr, mean height 184 cm, mean weight 83 kg) in response to epinephrine infusion or in response to saline infusion. The rate of epinephrine infusion was such that circulating epinephrine concentrations mimicked that typically seen during exercise. The level of IL-6 mRNA in subcutaneous adipose tissue increased 26-fold (95% confidence interval, 9- to 166-fold) at 3 h of epinephrine infusion compared with controls (P=0.028). In addition, plasma levels of IL-6 increased in response to epinephrine infusion (P<0.001). However, epinephrine did not affect the IL-6 receptor mRNA. In conclusion, epinephrine acutely increases IL-6 mRNA levels in subcutaneous adipose tissue as well as circulating IL-6 levels in healthy men.
引用
收藏
页码:1309 / 1312
页数:4
相关论文
共 50 条
[41]   Interleukin-6 expression and regulation in astrocytes [J].
Van Wagoner, NJ ;
Benveniste, EN .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 100 (1-2) :124-139
[42]   The association between serum prolactin levels and interleukin-6 and systemic lupus erythematosus activity [J].
Asyraf, W. A. Wan ;
Shahrir, M. S. Mohd ;
Asrul, W. ;
Norasyikin, A. W. ;
Hanita, O. ;
Kong, W. Y. ;
Azmi, M. T. .
REUMATISMO, 2018, 70 (04) :241-250
[43]   Raised interleukin-6 levels in obese patients [J].
Roytblat, L ;
Rachinsky, M ;
Fisher, A ;
Greemberg, L ;
Shapira, Y ;
Doudevani, A ;
Gelman, S .
OBESITY RESEARCH, 2000, 8 (09) :673-675
[44]   SERUM INTERLEUKIN-6 LEVELS IN PATIENTS WITH THROMBOCYTOSIS [J].
HOLLEN, CW ;
HENTHORN, J ;
KOZIOL, JA ;
BURSTEIN, SA .
LEUKEMIA & LYMPHOMA, 1992, 8 (03) :235-241
[45]   Increased peroxisome proliferator-activated receptor γ expression levels in visceral adipose tissue, and serum CCL2 and interleukin-6 levels during visceral adipose tissue accumulation [J].
Yogarajah, Thaneswary ;
Bee, Yvonne-Tee Get ;
Noordin, Rahmah ;
Yin, Khoo Boon .
MOLECULAR MEDICINE REPORTS, 2015, 11 (01) :515-520
[46]   CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis [J].
Padberg, F ;
Feneberg, W ;
Schmidt, S ;
Schwarz, MJ ;
Körschenhausen, D ;
Greenberg, BD ;
Nolde, T ;
Müller, N ;
Trapmann, H ;
König, N ;
Möller, HJ ;
Hampel, H .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 99 (02) :218-223
[47]   METHIONINE-ENKEPHALIN AUGMENTS INTERLEUKIN-6 PRODUCTION AND GENE-EXPRESSION [J].
ZHONG, F ;
LI, XY ;
YANG, SL .
ACTA PHARMACOLOGICA SINICA, 1995, 16 (03) :205-209
[48]   Inhibitory effects of glucocorticoids on urocortin-mediated increases in interleukin-6 gene expression in rat aortic smooth muscle cells [J].
Kageyama, Kazunori ;
Hanada, Komaki ;
Nigawara, Takeshi ;
Furukawa, Ken-Ichi ;
Terui, Ken ;
Ogura, Eriko ;
Motomura, Shigeru ;
Suda, Toshihiro .
PEPTIDES, 2007, 28 (05) :1059-1067
[49]   Serum and urinary interleukin-6 in systemic lupus erythematosus [J].
Peterson, E ;
Robertson, AD ;
Emlen, W .
LUPUS, 1996, 5 (06) :571-575
[50]   Interleukin-6: a new therapeutic target in systemic sclerosis? [J].
O'Reilly, Steven ;
Cant, Rachel ;
Ciechomska, Marzena ;
van Laar, Jacob M. .
CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2013, 2